Literature DB >> 19916949

Intestinal fibrosis in Crohn's disease: medical treatment or surgery?

Antonino Spinelli1, Carmen Correale, Hajnalka Szabo, Marco Montorsi.   

Abstract

Crohn's disease (CD) is a chronic panenteric disease of unknown aethiology tending to progress, inspite medical or surgical treatment. Intestinal fibrosis is among the most common complications of CD, resulting in stricture formation in the small intestine and colon. About 75% of CD patients will undergo surgery at least once over the course of their disease and fibrotic strictures represents the main indication for surgery and the first cause of hospitalization and costs for CD patients. Clinical management of intestinal strictures depends on the type of stricture: inflammatory strictures are treated medically and are usually responsive to treatment, while fibrotic strictures require surgery. Clinical decisions regarding the right treatment choice for such conditions require proper knowledge on what to expect from the emerging drug strategies and surgical techniques. To achieve optimal results in patients management an approach combining the expertise of both gastroenterologist and colorectal surgeon is essential. This review aims at providing clinicians with an overview on fibrotic strictures in CD patients particular focus will be placed on the principal imaging modalities, and the medical, endoscopic and surgical treatment options with relative indications, according to the most recent evidence available.

Entities:  

Mesh:

Year:  2010        PMID: 19916949     DOI: 10.2174/138945010790309984

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  19 in total

Review 1.  Crucial steps in the natural history of inflammatory bowel disease.

Authors:  Giovanni Latella; Claudio Papi
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

Review 2.  Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBD.

Authors:  Noam Jacob; Stephan R Targan; David Q Shih
Journal:  United European Gastroenterol J       Date:  2016-05-10       Impact factor: 4.623

3.  Dynamic Contrast-Enhanced Magnetic Resonance Enterography and Dynamic Contrast-Enhanced Ultrasonography in Crohn's Disease: An Observational Comparison Study.

Authors:  Rune Wilkens; David A Peters; Agnete H Nielsen; Valeriya P Hovgaard; Henning Glerup; Klaus Krogh
Journal:  Ultrasound Int Open       Date:  2017-02

Review 4.  Physiological and pathological role of local and immigrating colonic stem cells.

Authors:  Ferenc Sipos; Gábor Valcz; Béla Molnár
Journal:  World J Gastroenterol       Date:  2012-01-28       Impact factor: 5.742

5.  Comparison of CT enterography and MR enterography imaging features of active Crohn disease in children and adolescents.

Authors:  Heather I Gale; Steven M Sharatz; Mayureewan Taphey; William F Bradley; Katherine Nimkin; Michael S Gee
Journal:  Pediatr Radiol       Date:  2017-05-03

Review 6.  Purinergic signaling in scarring.

Authors:  Davide Ferrari; Roberto Gambari; Marco Idzko; Tobias Müller; Cristina Albanesi; Saveria Pastore; Gaetano La Manna; Simon C Robson; Bruce Cronstein
Journal:  FASEB J       Date:  2015-09-02       Impact factor: 5.191

7.  Detecting active inflammation and fibrosis in pediatric Crohn's disease: prospective evaluation of MR-E and CT-E.

Authors:  Keith B Quencer; Katherine Nimkin; Mari Mino-Kenudson; Michael S Gee
Journal:  Abdom Imaging       Date:  2013-08

Review 8.  Revisiting fibrosis in inflammatory bowel disease: the gut thickens.

Authors:  Silvia D'Alessio; Federica Ungaro; Daniele Noviello; Sara Lovisa; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-12-07       Impact factor: 46.802

9.  Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review.

Authors:  Dominik Bettenworth; Florian Rieder
Journal:  Fibrogenesis Tissue Repair       Date:  2014-03-29

Review 10.  The potential of mesenchymal stem cells in the management of radiation enteropathy.

Authors:  P-Y Chang; Y-Q Qu; J Wang; L-H Dong
Journal:  Cell Death Dis       Date:  2015-08-06       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.